Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

What 13 Analyst Ratings Have To Say About JB Hunt Transport Servs

Analysts have provided the following ratings for JB Hunt Transport Servs (NASDAQ:JBHT) within the last quarter:

Here's How Much $1000 Invested In Dollar Tree 5 Years Ago Would Be Worth Today

Here's How Much $1000 Invested In Dollar Tree 5 Years Ago Would Be Worth Today

Dollar Tree (NASDAQ:DLTR) has outperformed the market over the past 5 years by 7.71% on an annualized basis producing an average annual return of 17.64%. Currently, Dollar Tree has a market capitalization of $35.34 billion.

Overview Of Value Stocks In The Technology Sector

Overview Of Value Stocks In The Technology Sector

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What 5 Analyst Ratings Have To Say About Penn National Gaming

Within the last quarter, Penn National Gaming (NASDAQ:PENN) has observed the following analyst ratings:

Read How Cinedigm Fared In Q4

Cinedigm Corp (NASDAQ:CIDM) reported fourth-quarter FY22 revenue growth of 104% year-on-year to $16.9 million. High streaming revenues, including a 109% increase in ad-supported streaming revenues, which were also up 793% on a two-year basis, drove the increase. Total streaming minutes rose to 2.3 billion, up 118% Y/Y. Cinedigm’s total ad-supported streaming audience increased…

A Preview Of Patterson Companies's Earnings

Patterson Companies (NASDAQ:PDCO) is set to give its latest quarterly earnings report on Wednesday, 2022-06-29. Here's what investors need to know before the announcement. Analysts estimate that Patterson Companies will report an earnings per share (EPS) of $0.55.

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

SMART Global Holdings's Earnings: A Preview

SMART Global Holdings's Earnings: A Preview

SMART Global Holdings (NASDAQ:SGH) is set to give its latest quarterly earnings report on Wednesday, 2022-06-29. Here's what investors need to know before the announcement. Analysts estimate that SMART Global Holdings will report an earnings per share (EPS) of $0.75.

Bed Bath & Beyond Earnings Preview

Bed Bath & Beyond Earnings Preview

Bed Bath & Beyond (NASDAQ:BBBY) is set to give its latest quarterly earnings report on Wednesday, 2022-06-29. Here's what investors need to know before the announcement. Analysts estimate that Bed Bath & Beyond will report an earnings per share (EPS) of $-1.39.

Walgreens Retains Boots Business Ownership Amid Market Instability

Walgreens Retains Boots Business Ownership Amid Market Instability

Walgreens Boots Alliance Inc (NASDAQ:WBA) has decided to retain its Boots and No7 Beauty Company businesses under its existing ownership. The decision marks the conclusion of the review that began in January. The discussions Walgreens had with potential buyers did not yield expected results as the recent market instability severely impacted the financial availability…

Markets Open Higher; US Goods Gap Narrows To $104.3B In May

Markets Open Higher; US Goods Gap Narrows To $104.3B In May

U.S. stocks traded higher this morning, with the Dow Jones gaining over 350 points on Tuesday.

Looking Into VistaGen Therapeutics's Return On Capital Employed

Looking Into VistaGen Therapeutics's Return On Capital Employed

Benzinga Pro data, VistaGen Therapeutics (NASDAQ:VTGN) reported Q4 sales of $38.90 thousand. Earnings fell to a loss of $16.69 million, resulting in a 58.41% decrease from last quarter.

Smith & Wesson Brands's Return On Capital Employed Overview

Smith & Wesson Brands's Return On Capital Employed Overview

According to Benzinga Pro, during Q4, Smith & Wesson Brands (NASDAQ:SWBI) earned $36.13 million, a 18.31% increase from the preceding quarter. Smith & Wesson Brands also posted a total of $181.30 million in sales, a 2.0% increase since Q3.

RF Industries's Return on Invested Capital Insights

RF Industries's Return on Invested Capital Insights

According to Benzinga Pro, during Q2, RF Industries (NASDAQ:RFIL) earned $503.00 thousand, a 281.59% increase from the preceding quarter. RF Industries also posted a total of $21.50 million in sales, a 27.11% increase since Q1.

Get all your
news in one place.

100’s of premium titles.
One news app.

Looking Into Global Blood Therapeutics's Return On Capital Employed

According to Benzinga Pro data, during Q1, Global Blood Therapeutics (NASDAQ:GBT) posted sales of $55.16 million. Earnings were up 7.03%, but Global Blood Therapeutics still reported an overall loss of $81.42 million.

Hooker Furniture Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Hooker Furniture (NASDAQ:HOFT) earned $3.18 million, a 180.09% increase from the preceding quarter. Hooker Furniture also posted a total of $147.31 million in sales, a 9.28% increase since Q4.

Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases

Roivant Sciences Ltd (NASDAQ:ROIV) and Pfizer Inc (NYSE:PFE) unveiled Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases. Priovant was established in September 2021 through a transaction between Roivant and Pfizer. Pfizer licensed oral and topical brepocitinib's global development rights and US and Japan commercial rights to Priovant. Pfizer holds a 25%…

Tencent Targets Metaverse After Overseas Opportunities, EV To Drive Growth

Tencent Holding Ltd (OTC:TCEHY) acknowledged setting up a unit focused on exploring the space to tap multiple opportunities in extended reality (XR) technologies in the next 4-5 years, Reuters reports. Gaming chief Steven Ma disclosed that Tencent had set up an XR business line to combine hardware and software, betting on most…

Get all your
news in one place.

100’s of premium titles.
One news app.

Velodyne Shares Pop Post Multi-Year Agreement With Mobile Robotics Leader

Velodyne Lidar, Inc (NASDAQ: VLDR) forged a multi-year deal for its lidar sensors with Boston Dynamics, the global leader in mobile robotics. Boston Dynamics chose Velodyne's sensors to provide perception and navigation capabilities for its highly mobile robots. Velodyne's lidar sensor solutions enable mobile robots to operate autonomously and safely. They provide real-time 3D…

Analyst Ratings for Karuna Therapeutics

Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter:

Where Aspen Technology Stands With Analysts

Within the last quarter, Aspen Technology (NASDAQ:AZPN) has observed the following analyst ratings:

Why Trip.com Shares Are Surging Today

Trip.com Group Ltd (NASDAQ:TCOM) said its first-quarter FY22 sales remained flat year-on-year at RMB4.1 billion ($649 million). Net revenue decreased by 12% Q/Q. The sequential decrease was caused by the impact of the latest wave of COVID-19 resurgence in China. Accommodation reservation revenue fell 8% Y/Y, transportation ticketing increased 10%, packaged tours revenue…

Surging Gas Prices Make Tesla An Attractive Option For Some Uber, Lyft Drivers - Read How

Some Uber Technologies, Inc (NYSE: UBER) and Lyft, Inc (NASDAQ: LYFT) drivers found renting or buying a Tesla, Inc (NASDAQ:

Analyst Ratings for Microchip Technology

Within the last quarter, Microchip Technology (NASDAQ:MCHP) has observed the following analyst ratings:

Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK

Ideaya Biosciences Inc (NASDAQ:IDYA) has selected a potential first-in-class Pol Theta Helicase development candidate, a small molecule inhibitor of the helicase domain of DNA Polymerase Theta. Ideaya is collaborating with GSK plc (NYSE:GSK) on IND-enabling studies to support the evaluation of the Pol Theta Helicase candidate in combination with niraparib, GSK's PARP inhibitor, in tumors with…

1 … 351 352 353 354

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Virtual reality

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

351,523 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play